Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Parenthetical)

v3.26.1
Condensed Consolidated Balance Sheets (Parenthetical) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Statement of Financial Position [Abstract]    
Accounts receivable, allowance for credit losses $ 416,448 $ 389,079
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 100,000,000 100,000,000
Common stock, shares issued 29,905,229 29,846,479
Common stock, shares outstanding 29,905,229 29,846,479